AstraZeneca Creates Viela Bio from MedImmune Arm

04.03.2018 - MedImmune, the biologics R&D arm of Anglo-Swedish drugmaker AstraZeneca, is spinning out six molecules from its early-stage inflammation and autoimmunity programs into new...